Cargando…
Long-term treatment with anti-CD20 monoclonal antibodies is untenable because of risk: Commentary
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
SAGE Publications
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9189590/ https://www.ncbi.nlm.nih.gov/pubmed/35678609 http://dx.doi.org/10.1177/13524585221101138 |